Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancer Letters|May 29, 2012
MAGE-A antigens as targets in tumour therapyDavid W Meek, Lynnette MarcarCancer Research|November 9, 2010
Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatinLynnette Marcar, Nicola J Maclaine, Ted R Hupp, et al.Biochemistry and Biophysics Reports|August 17, 2021
The effect of serum starvation on tight junctional proteins and barrier formation in Caco-2 cellsAisling M Ross, Darragh R Walsh, Rachel M Cahalane, et al.The Journal of Biological Chemistry|May 10, 2008
Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphomaCarol Hogan, Caroline Hutchison, Lynnette Marcar, et al.Pharmaceutics|January 21, 2023
Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell BarrierAisling M Ross, Rachel M Cahalane, Darragh R Walsh, et al.FEBS Letters|January 27, 2009
FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53Anna Maria Ochocka, Petros Kampanis, Samantha Nicol, et al.Plos One|May 23, 2015
MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4Lynnette Marcar, Bianca Ihrig, John Hourihan, et al.Cell Cycle (Georgetown, Tex.)|October 22, 2010
p53-dependent repression of polo-like kinase-1 (PLK1)Lynsey McKenzie, Sharon King, Lynnette Marcar, et al.Cell Reports|June 20, 2019
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor SensitivityLynnette Marcar, Kankana Bardhan, Liliana Gheorghiu, et al.Oncogene|March 8, 2018
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53Qi Liu, Liliana Gheorghiu, Michael Drumm, et al.Pageof 2